HCPCS Code Descriptor:
Injection, cemiplimab-rwlc, 1 mg
Route of Administration:
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
LIBTAYO is an Oncology drug manufactured by Regeneron and administered via the Intravenous route of administration. The J Code: J9119 is aligned to the drug LIBTAYO.
Access Pricing and More By Registering
HCPCS Added Date:
HCPCS Effective Date:
HCPCS Short Description:
Inj., cemiplimab-rwlc, 1 mg
Billing and Coding Guide: